Since the outbreak of the epidemic, some domestic biopharmaceutical companies have been actively developing COVID-19 vaccine to cope with the epidemic. Among them, Kexing vaccine is also a major vaccine brand representing the domestic market. Kexing's net profit is nearly 50 billion, and it is vaccinated for free. What is its profit point?

Although our vaccines are completely free for ordinary people, it does not mean that no one pays for these free vaccines. For example, people who pay for vaccines include national financial and medical insurance institutions. Vaccine research and development has its own costs. Since there is a cost, it involves the price. This part of the cost is mainly from the medical insurance fund and finance, but for ordinary people, we don't have to pay this money. Because vaccination is also a means for the China government to benefit the people.

But for enterprises, their goal is to make a profit. In particular, various biomedical technologies are the main direction of the country's vigorous development and support, and the development and vaccination of vaccines are related to the prevention and control of national epidemics. Specifically, the cost burden and income sources of vaccines in COVID-19 include the national procurement of enterprises, the state's full support for the research and development expenses of biological products invested in the early stage, international procurement and sales, and national procurement to provide assistance to other countries.

What we need to be clear is that the state has always given full support to pharmaceutical companies that are related to the national economy and people's livelihood, so there will never be a situation where there is no money to make. Only when the country is in danger, these pharmaceutical companies have to come forward and try their best to use the call of the country to vaccinate the people for free. Of course, behind this, the state finance and government should provide funds for it to transport a large number of inactivated vaccines to all parts of the country and implement basic comprehensive coverage vaccination. People should also actively respond to the government's call and actively cooperate, which is also responsible for themselves and others.

At present, the population of China is 654.38+0.4 billion. According to official data, 654.38 billion people in China have been vaccinated, and at least two injections are needed. As far as possible, the government procurement revenue at the cost price alone is already very considerable. If calculated twice per capita, a Kexing vaccine has the cost of 200 yuan. At present, this vaccine has already spent 4,000 yuan.